You are now leaving the Novartis site and moving to an external website independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or click OK to continue.
PLUVICTO Drug Shortage Has Been Resolved
Novartis remains committed to ensuring PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) is available. We are accepting orders for all doses within the PLUVICTO treatment cycle. To find the treatment center nearest you, speak with your doctor or use our treatment center locator.